Related Experiment Video
Updated: Jan 11, 2026

Synthesis of Infectious Bacteriophages in an E. coli-based Cell-free Expression System
Published on: August 17, 2017
Genome synthesis, assembly, and rebooting of therapeutically useful high G+C% mycobacteriophages
Ching-Chung Ko1, Andrew P Sikkema2, Michael J Lauer1
1Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
Abstract:
Bacteriophages show therapeutic promise for treating bacterial pathogens including nontuberculous mycobacteria (NTM). A major impediment is the paucity of therapeutically useful phages and the great variation in the phage infection profiles, especially among Mycobacterium abscessus clinical isolates. These limitations-together with the abundance of mycobacteriophage genes of unknown function-could be addressed by synthetic genetic construction of viruses in which undesirable genes can be eliminated and genetic payloads can be readily added. However, the relatively high G+C% content of mycobacteriophage genomes (64.1%) can be challenging for DNA synthesis using phosphoramidite chemistry, and the genomes are relatively large (40 to 150 kbp) for assembly and rebooting in a bacterial host. Here, we demonstrate efficient de novo synthesis of high G+C% DNA fragments using terminal deoxynucleotidyl transferase chemistry, the reconstruction of complete mycobacteriophage genomes using High-Complexity Golden Gate Assembly, and efficient rebooting via electroporation into Mycobacterium smegmatis. Using this approach, we synthesized the genomes of phages BPs (41.9 kbp, 66.6% G+C%) and Bxb1 (50.5 kbp, 63.6% G+C%), and constructed variants carrying targeted mutations or added payloads. Synthetic construction of mycobacteriophages and their derivatives expands the phage repertoire for therapeutic development and provides versatile tools for advancing mycobacterial genetics and phage-based clinical applications.
Insights
Synthetic biology enables the creation of novel bacteriophages for treating nontuberculous mycobacteria (NTM). This research developed methods to synthesize and modify mycobacteriophage genomes, expanding therapeutic options.
Area of Science:
- Synthetic biology
- Virology
- Genetics
Background:
- Bacteriophages are promising therapeutics for bacterial infections, including nontuberculous mycobacteria (NTM).
- Limited availability and variable infection profiles of natural phages hinder therapeutic development.
- Mycobacteriophage genomes are large and have high G+C content, posing challenges for synthetic manipulation.
Purpose of the Study:
- To develop efficient methods for de novo synthesis and genetic engineering of mycobacteriophage genomes.
- To overcome challenges associated with high G+C content and large genome size in mycobacteriophages.
- To expand the repertoire of mycobacteriophages for therapeutic applications and mycobacterial research.
Main Methods:
- Utilized terminal deoxynucleotidyl transferase chemistry for high G+C% DNA synthesis.
- Employed High-Complexity Golden Gate Assembly for complete mycobacteriophage genome reconstruction.
- Demonstrated efficient genome rebooting via electroporation into *Mycobacterium smegmatis*.
Main Results:
- Successfully synthesized genomes of phages BPs (41.9 kbp, 66.6% G+C%) and Bxb1 (50.5 kbp, 63.6% G+C%).
- Constructed synthetic phage variants with targeted mutations and added genetic payloads.
- Validated the efficiency of the synthetic genome assembly and rebooting process.
Conclusions:
- Synthetic construction provides a versatile platform for creating custom mycobacteriophages.
- This approach expands the toolkit for phage-based therapeutics against NTM.
- Enables advancements in mycobacterial genetics and phage-based clinical applications.
Related Concept Videos
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages
Lytic Cycle of Bacteriophages
Homologous Recombination
Viral Recombination
Synthetic Biology
Golden rice
Golden rice is a genetically modified...

